MPJE Federal 4

Question 1

Under HIPAA, which of the following is considered a permissible disclosure of protected health information (PHI) without patient authorization?

Accepted Answer

Providing PHI to a public health authority for disease surveillance

Answer

Sharing PHI with a marketing company for advertising purposes

Answer

Disclosing PHI to an employer for pre-employment screening

Answer

Releasing PHI to a law firm for civil litigation without a court order

Question 2

Under the federal DEA regulations, an automated dispensing cabinet (ADC) in a hospital must have which of the following for Schedule II controlled substances?

Accepted Answer

Biometric access and perpetual inventory records

Answer

A separate DEA registration from the hospital pharmacy

Answer

Dual-pharmacist sign-off for each withdrawal

Answer

A separate DEA Form 222 for each ADC fill

Question 3

A pharmacist receives a faxed prescription for a Schedule II controlled substance from a physician. Under federal law, when may this fax serve as the original prescription?

Accepted Answer

When the patient is in a long-term care facility, hospice, or the substance is a compounded product for home infusion

Answer

Never; Schedule II prescriptions must always be written originals

Answer

When the prescriber provides a verbal authorization within 7 days

Answer

When the pharmacy is located in a rural health shortage area

Question 4

Under the Controlled Substances Act, an emergency oral Schedule II prescription must be dispensed in what quantity?

Accepted Answer

Only the quantity adequate to treat the patient during the emergency period

Answer

A full 30-day supply

Answer

A maximum of a 72-hour supply

Answer

Any quantity at the pharmacist's professional judgment

Question 5

The Drug Addiction Treatment Act of 2000 (DATA 2000) allowed qualifying physicians to prescribe which controlled substance for the office-based treatment of opioid use disorder?

Accepted Answer

Buprenorphine

Answer

Methadone

Answer

Naltrexone

Answer

Naloxone

Question 6

Which federal regulation governs the requirements for pharmacy compounding under Section 503A of the FDCA?

Accepted Answer

Compounding under 503A is permitted for individual patient prescriptions and must be based on a valid patient-specific prescription

Answer

Compounding is only permissible for licensed outsourcing facilities registered with the FDA

Answer

Pharmacies may compound any FDA-approved drug in unlimited quantities for office use

Answer

Compounded preparations under 503A are exempt from all USP standards

Question 7

Under the Controlled Substances Act, which of the following describes an 'electronic prescription for controlled substances' (EPCS)?

Accepted Answer

A prescription created, signed, transmitted, and received using DEA-compliant software with two-factor authentication

Answer

A prescription sent via secure email attachment

Answer

A prescription scanned and uploaded to a pharmacy portal

Answer

A faxed prescription with a digital signature overlay